Overexpression of ALKBH5 decreases TGFβR2 and SMAD3 expression and mRNA stability, while increasing SMAD6, resulting in reduced TGF-β signaling, EMT, and invasion of NSCLC cells. Here, ALKBH5 is linked to non-small cell lung carcinoma.